Montelukast and the risk of neuropsychiatric reactions
Posted by Web Team in
The MHRA have issued a reminder to healthcare professional on the possible neuropsychiatric reactions that may occur with montelukast. It ...
Read more
Posted by Web Team in
The MHRA have issued a reminder to healthcare professional on the possible neuropsychiatric reactions that may occur with montelukast. It ...
Read morePosted by Web Team in
Guidance has been published that sets out the actions adult social care providers should take before and after Brexit, to ...
Read morePosted by Web Team in
We understand that our clients are concerned if customs and trading arrangements between UK and EU change following the UK’s ...
Read more
Posted by Web Team in
NICE have produced a quick guide to provide information about giving medication covertly. Care staff need to be aware of the ...
Read morePosted by Web Team in
Zaponex tablets are now available in an orodispersible formulation with strengths of 12.5mg, 25mg, 50mg, 100mg, 200mg. They are monitored ...
Read more